MLMIB.PA Metrics in Balance NV

Healthcare Health Care Providers & Services Euronext Paris
0.0330 EUR
Close of Oct 14, 2026
0.0330 0.0330
Market cap
EUR 145K
P/E
-
P/B
0.07x
ROE
-0.2%
Dividend yield
-
Fundamental score
2.5/5

Ratios use the latest price and the fiscal year ending Dec 2025.

Is MLMIB.PA undervalued?

Graham number

The Graham number of Metrics in Balance NV cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Metrics in Balance NV fundamental analysis

7 of 11 checks passed

ROE 1/2

ROE in an average range (0.02%) suggests satisfactory profitability and decent utilization of shareholders' equity.

ROA 1/2

The stock's ROA (0.02%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

PBV 2/2

With a remarkably low PBV ratio (0x), the stock offers substantial upside potential at a bargain price.

DER 2/2

The stock has a low debt to equity ratio (1%), which means it has a small amount of debt compared to the ownership it holds

Revenue Growth 1/2

Over the past three years, this company's revenue has consistently grown, demonstrating a positive financial trend that makes it an appealing choice.

Net Profit Growth 1/2

The net profit of this company has shown steady growth over the past three years, highlighting its positive financial trajectory and making it an appealing choice for potential investors.

Assets Growth 2/2

Over the past five years, this company's revenue has consistently increased, demonstrating a robust financial performance that makes it an appealing opportunity.

Graham Number 0/1

The Graham number calculation reveals that this company's stock price is potentially inflated, implying that it may not be a desirable investment option.

Dividend Growth 0/2

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

Dividend 0/2

The company's lack of dividends in the past three years may concern investors seeking regular income.

Buffet Intrinsic Value 0/1

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Metrics in Balance NV stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Metrics in Balance NV

Metrics in Balance N.V. owns and operates healthcare clinics in the Netherlands. It also engages in the chiropractic care and physical therapy, lifestyle testing, and occluso-posture therapy services. The company was incorporated in 2016 and is headquartered in Gent, Belgium.

Full company profile